Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA004200-14
Application #
2043057
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
1988-05-01
Project End
1998-06-30
Budget Start
1996-07-01
Budget End
1998-06-30
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Name
East Carolina University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Greenville
State
NC
Country
United States
Zip Code
27858
McMillen, Brian A; Joyner, Paul W; Parmar, Chandresh A et al. (2004) Effects of NMDA glutamate receptor antagonist drugs on the volitional consumption of ethanol by a genetic drinking rat. Brain Res Bull 64:279-84
Mega, Benjamin T; Sheppard, Katherine W; Williams, Helen L et al. (2002) On the role of monoamine oxidase-A for the maintenance of the volitional consumption of ethanol in two different rat models. Naunyn Schmiedebergs Arch Pharmacol 366:319-26
West, M W; Biggs, T A; Schreiber, R et al. (1999) Calcium channel agonist (-)-BAY k 8644 suppresses free and limited access intake of alcohol in genetic drinking rats. Psychopharmacology (Berl) 142:261-9
Myers, R D; Robinson, D E (1999) Tetrahydropapaveroline injected in the ventral tegmental area shifts dopamine efflux differentially in the shell and core of nucleus accumbens in high-ethanol-preferring (HEP) rats. Alcohol 18:83-90
Myers, R D; Robinson, D E (1999) Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats. Alcohol 18:225-33
Jones, E A; McMillen, B A (1999) The cardiovascular effects of amperozide: interactions with cocaine. Pharmacol Toxicol 84:53-8
Biggs, T A; Myers, R D (1998) Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats. Pharmacol Biochem Behav 60:407-13
West, M W; Kalmus, G; Myers, R D (1998) Limited access to ethanol in genetic drinking rats is suppressed while feeding is enhanced by the mixed 5-HT1A agonist/5-HT2A antagonist FG5938. Pharmacol Biochem Behav 60:823-8
West, M W; Biggs, T A; Tavares, E et al. (1998) Drinking patterns in genetic low-alcohol-drinking (LAD) rats after systemic cyanamide and cerebral injections of THP or 6-OHDA. Alcohol 15:239-47
Wilcox, R E; McMillen, B A (1998) The rational use of drugs as therapeutic agents for the treatment of the alcoholisms. Alcohol 15:161-77

Showing the most recent 10 out of 72 publications